ArticleJournal of patient-reported outcomes2021

Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors.

Robert Knoerl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.